Tumor immune evasion arises through loss of TNF sensitivity
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Whole-genome CRISPR screens identify resistance to TNF-mediated killing by T and NK cells as a tumor immune evasion mechanism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IFN γ and TNF α are key effector cytokines that contribute to anti-tumour immune responses 9,11,27-30 , and genes associated with IFN and TNF signaling pathways contribute to immune evasion 4,9,29 .”
From Targeting TBK1 to overcome resistance to cancer immunotherapy (2023) · cites this paper as [29]
In the citing paper
“Single-guide RNAs targeting genes involved in IFN γ sensing (Ifngr1, Ifgnr2, Jak1, Jak2, and Stat1) were enriched in control and Tbk1-null cells (Fig. 5d, Extended Data Fig. 10a), consistent with previous in vivo and in vitro screens 4,29 .”
From Targeting TBK1 to overcome resistance to cancer immunotherapy (2023) · cites this paper as [29]
Citations
Cites
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
Rizvi, N. A., Hellmann, M. D., Snyder, A., Kvistborg, P., Makarov, V., Havel, J. J., Lee, W., Yuan, J., Wong, P., Ho, T. S., et al. (2015) · Science · doi:10.1126/science.aaa1348 · Cited by 7,802
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Doench, J. G., Fusi, N., Sullender, M., Hegde, M., Vaimberg, E. W., Donovan, K. F., Smith, I., Tothova, Z., Wilen, C., Orchard, R., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3437 · Cited by 4,637 · cited 1×
“The mouse cell lines MC38-Cas9, MC38OvaCas9, and B16Ova-Cas9 cells were transduced with the Brie genome-wide sgRNA library (40), and the human cell line MDA-MB-231 was transduced with the Brunello genome-wide sgRNA library.”
MethodMutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
Zaretsky, J. M., Garcia-Diaz, A., Shin, D. S., Escuin-Ordinas, H., Hugo, W., Hu-Lieskovan, S., Torrejon, D. Y., Abril-Rodriguez, G., Sandoval, S., Barthly, L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1604958 · Cited by 3,237 · cited 3×
“Gene mutations that reduce the efficacy of immunotherapy have recently been identified, including mutations in Janus kinases (JAK) providing resistance to anti–PD-1 therapy (9).”
BackgroundClonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade
McGranahan, N., Furness, A. J. S., Rosenthal, R., Ramskov, S., Lyngaa, R., Saini, S. K., Jamal-Hanjani, M., Wilson, G. A., Birkbak, N. J., Hiley, C. T., et al. (2016) · Science · doi:10.1126/science.aaf1490 · Cited by 3,065
Li, W., Xu, H., Xiao, T., Cong, L., Love, M. I., Zhang, F., Irizarry, R. A., Liu, J. S., Brown, M., & Liu, X. S. (2014) · Genome Biology · doi:10.1186/s13059-014-0554-4 · Cited by 2,684
Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations
Shin, D. S., Zaretsky, J. M., Escuin-Ordinas, H., Garcia-Diaz, A., Hu-Lieskovan, S., Kalbasi, A., Grasso, C. S., Hugo, W., Sandoval, S., Torrejon, D. Y., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1223 · Cited by 1,337
Perforin and granzymes: function, dysfunction and human pathology
Voskoboinik, I., Whisstock, J. C., & Trapani, J. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3839 · Cited by 1,327
Self-citationGenome-scale CRISPR-Cas9 Knockout and Transcriptional Activation Screening
Joung, J., Konermann, S., Gootenberg, J. S., Abudayyeh, O. O., Platt, R. J., Brigham, M. D., Sanjana, N. E., & Zhang, F. (2017) · Nature Protocols · doi:10.1038/nprot.2017.016 · Cited by 1,243 · cited 1×
“Genomic DNA extraction was subsequently performed using the DNeasy Blood & Tissue Kit (Qiagen), and libraries were prepared as described previously (41).”
MethodIn vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
Manguso, R. T., Pope, H. W., Zimmer, M. D., Brown, F. D., Yates, K. B., Miller, B. C., Collins, N. B., Bi, K., LaFleur, M. W., Juneja, V. R., et al. (2017) · Nature · doi:10.1038/nature23270 · Cited by 1,147
Cited by
Items 301–400 of 405
Tu, Z., Ji, Q., Han, Q., Long, X., Li, J., Wu, L., Huang, K., & Zhu, X. (2022) · BMC Cancer · doi:10.1186/s12885-022-09984-5 · Cited by 3
HSPA5 regulates the expression and alternative splicing of inflammatory and immune response genes.Preprint
Fan, H., Xue, L., Liu, Y., Zuo, D., Gao, F., Li, H., Zhang, L., & Shou, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-397944/v1 · Cited by 3
Evolutionary trajectories of immune escape across cancersPreprint
Chen, W., Baker, T. M., Zhang, Z., Ogilvie, H. A., Loo, P. V., & Gu, S. S. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.17.632799 · Cited by 3
Differentiation status determines tumorigenicity and immunogenicity of cancer cellsPreprint
Liu, Y., Wang, C., Li, H., & Cao, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.30.656250 · Cited by 3
Lin, M. J., Chorazeczewski, J. K., Pantsulaia, G., Cooper, A., Sohn, M., Reci, S., Mateus-Tique, J., Hirsh, N. H., Xie, X.-P., Odak, I., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.22.677496 · Cited by 3
RNF19B confers tumor resistance to CAR T cellsPreprint
Geiger, R., Vogel, I. A., Casagranda, A., Cattaneo, M., Morosi, L. G., Pecoraro, M., Sulheim, E., & Basso, C. (2025) · Research Square · doi:10.21203/rs.3.rs-7847831/v1 · Cited by 3
Wolf, N. K. (2022) · eScholarship (California Digital Library) · Cited by 3
Inhibiting tumor cell-intrinsic UBA6 by inosine augments tumor immunogenicity
He, B., Zhang, L., Jiang, L., Yu, L., Li, Q., Tian, X., He, J.-Q., Zeng, L., Yang, Y., Wang, C., et al. (2021) · doi:10.21203/rs.3.rs-620390/v1 · Cited by 82
Li, N., Wang, L., Yao, J., & Yang, H. (2025) · Cytotechnology · doi:10.1007/s10616-025-00755-1 · Cited by 2
Inhibitory effect of Endostar on HIF-1 with upregulation of MHC-I in lung cancer cells
Zhao, M., Zheng, H.-F., Wang, J.-N., Zhang, Y., Wang, H., & Zhao, Z.-W. (2025) · Cancer Biology & Therapy · doi:10.1080/15384047.2025.2508535 · Cited by 2
The proteomics and phosphoproteomics landscape of melanoma under T cell attack
Franciosa, G., Jensen, A. W. P., Martínez‐Val, A., Piga, I., Donia, M., & Olsen, J. V. (2026) · Cell Reports Medicine · doi:10.1016/j.xcrm.2026.102829 · Cited by 2
Multi-omics analysis reveals ultraviolet response insights for immunotherapy and prognosis
Zhang, D., Dai, M., Ying, J., Huang, Y., Liu, Z., & Wu, C. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1598070 · Cited by 2
Chen, X., Wang, K., Zhou, S., Huang, J., Zhang, H., Huang, C., Yang, C., & Zeng, J. (2026) · ACS Omega · doi:10.1021/acsomega.5c11091 · Cited by 2
Gao, X., Yu, Y., Sun, J., Zhao, H., You, Y., Shi, X., Wang, K., Hong, S., Xiong, X., Huang, C., et al. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003647 · Cited by 2
mTORC1 suppression by Trp53 mutation drives resistance to immune checkpoint blockade
Labani‐Motlagh, A., Li, Y., Gao, D. S., Lee, E., Chen, V. J., Yi, L., Gao, F., Sun, R., Xu, J., Shoush, J., et al. (2026) · Cell Death and Disease · doi:10.1038/s41419-026-09067-4 · Cited by 2
New approaches to vaccines for cancer
Chavda, V. P., Acharya, D., Malla, S., Ashby, C. R., & Tiwari, A. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18564-9.00009-6 · Cited by 2
Pan-cancer analysis of T-cell proliferation regulatory genes as potential immunotherapeutic targets
Wei, R., Xiao, S., Zhao, S., Guo, W., Liu, Y., Requena, M., Alarcón, R., Wei, Q., & Wu, Y. (2024) · Aging · doi:10.18632/aging.205977 · Cited by 2
Inhibition of tumor autophagy: a strategy to improve anti-tumor immunity?
Freeman, A. J., Lelliott, E. J., & Oliaro, J. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00429-8 · Cited by 2
Self-citationBase-editing a single missense mutation in A20 enhances CAR-T cell efficacyPreprint
Blaisdell, A., Bachl, S., Sandoval, L. R., Ching, C., Bowman, C., Kale, N., Prabandham, M., Diolaiti, M. E., Havig, C. C., Advincula, R., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.05.680562 · Cited by 2
Guttormson, M. C., Krogman, E. N., Carr, A. R., Rizzo, S. A., Muske, J., Ziaee, M., Therrien, N. R., Sun, N. D., Ghale, R., Medlyn, M. J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.23.696308 · Cited by 2
Zhuang, X., & Long, E. O. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2160-8_19 · Cited by 1
Aljabali, A. A. A., Gammoh, O., Obeid, M. A., Qnais, E. Y., Alqudah, A. M., El‐Tanani, M., & Hatahet, T. (2025) · Current Cancer Drug Targets · doi:10.2174/0115680096381121250628142857 · Cited by 1
Yuan, F., Li, X., Hong, C., & Huang, X. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70621 · Cited by 1
Yu, Z., He, Y., Wang, M., Shen, J., Wang, D., Yu, A., Gu, J. F., Hong, Z., Pei, Z., & Sun, X. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102597 · Cited by 1
TNF-α deficiency underlies NK cell dysfunction in colorectal cancer
Ruggeri, S., Pizzitola, B., Laffranchi, M., Beltrame, L., Sciumè, G., Grimaldi, A., Fiori, E., Caronna, R., Peppo, V. D., Grazi, G. L., et al. (2026) · OncoImmunology · doi:10.1080/2162402x.2026.2636311 · Cited by 1
Rädler, P. D., Felsheim, B., Fernández-Martínez, A., Pfefferle, A. D., Hayward, M. C., Singh, B., Sikov, W. M., Carey, L., & Perou, C. M. (2026) · Journal of Clinical Investigation · doi:10.1172/jci205962 · Cited by 1
ZNF296 Drives Immune Evasion in Epithelial Cancers by Repressing Immune Stimulatory Genes
Wang, H., Zhao, F., Li, Y., Wang, P., Wang, Y., Ren, P., Li, C., Zheng, H., Zeng, Z., & Pan, D. (2025) · Cancer Research · doi:10.1158/0008-5472.can-25-0153 · Cited by 1
Liu, Y., Li, J., Xu, L., Liu, H.-F., Wu, C., Shan, S., & Gong, W. J. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000004102 · Cited by 1
Pasquier, A., Viu-Idocin, C., Arricibita, A., Echepare, M., Picabea, B., Orive, D., Álava, A., Fernández‐Irigoyen, J., Santamaría, E., Argueta, A., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117087 · Cited by 1
King-Peoples, T. R., Keane, J. T., Lewis, H.-G. S., Liu, F., Brookens, S. K., Dagher, O. K., Parvathaneni, K., Gardner, B. L., Ahmed, A., Furth, E. E., et al. (2026) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-26-0009 · Cited by 1
Levchuk, K., Goldaeva, A., Stolyarova, E. A., Матейкович, П. А., Валиуллина, А. Х., Bulatov, E., Petukhov, A., Daks, A. A., Barlev, N. A., Baidyuk, E. V., et al. (2023) · Clinical oncohematology · doi:10.21320/2500-2139-2023-16-3-268-279 · Cited by 1
Panoptosis – new frontier in research in head neck cancer
Mali, S. B. (2024) · Oral Oncology Reports · doi:10.1016/j.oor.2024.100310 · Cited by 1
The essential elements of adaptive immunity and their relevance to cancer immunology
Bullock, T. N. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-87763-3.00016-2 · Cited by 1
Zheng, Z., Gong, L., Zhong, H., Huang, B., Cong, Y., Zhong, B., & Wang, Z. (2025) · Eurasian Journal of Medicine and Oncology · doi:10.36922/ejmo025180152 · Cited by 1
Prade, S., Wright, D., Logan, N., Teagle, A. R., Stauss, H. J., & Zamoyska, R. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.03.410043 · Cited by 1
Xu, Y., & Rogers, C. J. (2021) · Research Square · doi:10.21203/rs.3.rs-180530/v1 · Cited by 1
Mapping the Genetic Determinants of T-cell Cytotoxicity Response in Cancer Cells
Akthar, R. (2020) · TSpace (University of Toronto) · Cited by 1
T cells in solid tumors : investigating the immunomodulation in the tumor microenvironment
Hartana, C. A. (2018) · Figshare
Genetic manipulation and genetic-based dissection of tumor-specific immunity
Mezzadra, R. (2019) · Data Archiving and Networked Services (DANS)
Pooling Functional Genetic Screens to Identify Genetic Correlates of Tumor Immunotherapy Response
Chang, A. E. B. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Wong, Y. Y., Riggan, L., Reyes, E. P., Huerta, C., Moldenhauer, M. R., & O’Sullivan, T. E. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.23.394353
Haarich, M., Leisten, I., Richert, A. J., & Jeschke, S. (2012) · EDULEARN proceedings
Pommier, Y. G. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735080728.793557582
Modeling Resistance to Immune Checkpoint Blockade
Quigley, M. M., Meyer, M. J., & Katlinski, K. V. (2022) · Wiley eBooks · doi:10.1002/9781119535331.ch4
An immune evasion molecular subgroup predicts prognosis in lung adenocarcinomaPreprint
lu, X., zhang, H., Zhang, Z., li, Z., Du, M., & Chen, B. (2022) · Research Square · doi:10.21203/rs.3.rs-2161529/v1
Zhong, Q., Butera, F., Frankel, G. M., & Bakal, C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.03.530985
Nguyen, T.-T., Ramsay, L., Ahanfeshar-Adams, M., Lajoie, M., Schadendorf, D., Alain, T., & Watson, I. R. (2023) · doi:10.1158/1078-0432.c.6530153
Nguyen, T.-T., Ramsay, L., Ahanfeshar-Adams, M., Lajoie, M., Schadendorf, D., Alain, T., & Watson, I. R. (2023) · doi:10.1158/1078-0432.c.6530153.v1
Data from BET Inhibition Enhances TNF-Mediated Antitumor Immunity
Wellinger, L. C., Hogg, S. J., Newman, D. M., Friess, T., Geiss, D., Michie, J., Ramsbottom, K. M., Bacac, M., Fauti, T., Marbach, D., et al. (2023) · doi:10.1158/2326-6066.c.6550757
Self-citationLong, Y., Chen, R., Yu, X., Tong, Y., Peng, X., Li, F., Hu, C., Sun, J., & Gong, L. (2023) · doi:10.1158/2326-6066.c.6551144
Sahu, A. D., Wang, X., Munson, P. B., Klomp, J. P. G., Wang, X., Gu, S. S., Han, Y., Qian, G., Nicol, P. B., Zeng, Z., et al. (2023) · doi:10.1158/2159-8290.22543005
Qu, F., Bao, S., Liu, Q., Wu, X., Jiang, M., Wang, X., Lu, R., Huang, X., Yin, Y., & Li, W. (2023) · Research Square · doi:10.21203/rs.3.rs-2807495/v1
Identification de nouvelles cibles potentielles impliquées dans l’immunomodulation tumorale
Aubert, N. (2022) · theses.fr (ABES) · doi:10.70675/9de9ead5z7e27z483bzb011z1abda090fa04
Jou, E. (2024) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.03.036
Ye, B., Fan, J., Meng, Q., Liang, X., Jiang, A., & Zhang, P. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.15.618438
Immune-oncology potential of KRAS inhibitors
Molina‐Arcas, M., Boumelha, J., & Downward, J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21861-3.00013-9
Virazels, M. (2023) · theses.fr (ABES) · doi:10.70675/1ffc7bb5z666fz49d3zb5b9z81ce3e4d33d5
Rachunek, K., Krauß, S., Daigeler, A., Adams, C., Eckert, F., Ganser, K., González-Menéndez, I., Quintanilla‐Martínez, L., & Kolbenschlag, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1501885
Rôle du métabolisme du céramide dans la dédifférenciation du mélanome induite par le TNF
Dufau, C. (2022) · theses.fr (ABES) · doi:10.70675/bb57f4daz823dz47d5zbc4fz992c243e466b
Abdelsamea, S. M., El-Emshaty, H. M., Othman, O., Sultan, A., & Ismail, H. (2025) · Egyptian Journal of Chemistry · doi:10.21608/ejchem.2025.339164.10880
Wu, C., Xue, W., Zhuang, Y., Duan, D. D., Zhou, Z., Wang, X., Wu, Z., Zhou, J., Huan, X., Wang, R., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1611890
Zhou, X., Yan, Z., Yang, J., Tang, J., Cen, W.-C., Cui, J., Teng, W., Ling, Y., Long, N., Guo, Z., et al. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110859
Transcription factor Zfx regulates tumor’s evasion to T cell killing in immunotherapy
Kaufmann, U., Wang, J., Callow, M. G., Fortin, J., Myrta, S., Nickles, D., Reja, R., Cheng, E., Wonder, E. L., Haley, B., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113842
Zhang, Z., Wang, Z.-X., Chen, Y.-X., Wu, H.-X., Yin, L., Zhao, Q., Luo, H.-Y., Zeng, Z., Qiu, M., & Xu, R.-H. (2022) · Figshare · doi:10.6084/m9.figshare.19687417
Wang, X., Chan, S., Chen, J., Xu, Y., Dai, L., Han, Q., Wang, Z., Zuo, X., Yang, Y., Zhao, H., et al. (2024) · Figshare · doi:10.6084/m9.figshare.25124002
Cho, J.-W., Cao, J., & Hemberg, M. (2024) · Figshare · doi:10.6084/m9.figshare.26690773
Cho, J.-W., Cao, J., & Hemberg, M. (2024) · Figshare · doi:10.6084/m9.figshare.26690782
Cho, J.-W., Cao, J., & Hemberg, M. (2024) · Figshare · doi:10.6084/m9.figshare.26690770
Gong, Z., Jia, Q., Guo, J., Li, C., Xu, S., Jin, Z., Chu, H., Wan, Y. Y., Zhu, B., & Zhou, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26560856
Cho, J.-W., Cao, J., & Hemberg, M. (2024) · Figshare · doi:10.6084/m9.figshare.26690767
Cui, Y., Li, J., Zhang, P., Yin, D., Wang, Z., Dai, J., Wang, W., Zhang, E., & Guo, R. (2023) · Figshare · doi:10.6084/m9.figshare.23499401
Cho, J.-W., Cao, J., & Hemberg, M. (2024) · Figshare · doi:10.6084/m9.figshare.25374702
Cho, J.-W., Cao, J., & Hemberg, M. (2024) · Figshare · doi:10.6084/m9.figshare.26690779
Cho, J.-W., Cao, J., & Hemberg, M. (2024) · Figshare · doi:10.6084/m9.figshare.26690776
Zhang, Z., Wang, Z.-X., Chen, Y.-X., Wu, H.-X., Yin, L., Zhao, Q., Luo, H.-Y., Zeng, Z.-L., Qiu, M., & Xu, R.-H. (2022) · Figshare · doi:10.6084/m9.figshare.19687414
Cho, J.-W., Cao, J., & Hemberg, M. (2024) · Figshare · doi:10.6084/m9.figshare.25374853
Martignier, C. (2021) · IRIS
Identifying the Metabolic Role of ADO in Liver Cancer Cells
Pyo, A. H. A. (2024) · TSpace (University of Toronto)
Lethal toxin–equipped effector cells for the potential treatment of cancer
Pearlman, A. H., Mog, B. J., Hwang, M. S., Rincón-Torroella, J., DiNapoli, S. R., Paul, S., Douglass, J., Hsiue, E. H.-C., Glavaris, S. A., Pardoll, D. M., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2506991123
Yu, X., Hao, X., Chen, M., & Baigude, H. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00495
Control of antitumor immunity by the SQSTM1 dependent signaling
Yazbeck, N. (2018) · theses.fr (ABES) · doi:10.70675/3eee578bzb29fz4a95z8a1az99fa6d5edb80
Etude des mécanismes de régulation de l'activation des cellules natural killer
Guia, S. (2021) · theses.fr (ABES) · doi:10.70675/fe8a748dzb006z40a0z8e07z1043717cbdd0
Optimisation de traitements immunothérapeutiques dans le cancer
Chavanton, A. (2024) · theses.fr (ABES) · doi:10.70675/7ea8dbe3z70b3z448fz90cez6a61ae774c59
Liu, L., Chen, S., Ding, M., Duan, Y., Pu, L., Li, L., Peng, H., & Yu, Q. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1787786
Zhou, F., Chen, T., Tan, X., Yu, J. Q., Mengzhi, X., & Guo, J. (2026) · The FASEB Journal · doi:10.1096/fj.202503004rr
Wang, S., Hou, S., Luo, C., Zhang, H., Jin, Y., Zhang, R., Zhao, Y., Xiong, X., Guo, R., Wang, C., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-73241-7
Chen, C., Liu, S., Feng, J., Luo, Z., Bi, Y., Huang, Q. C., Zhang, Y., Yu, H., Wu, J., Yu, H., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116141
Xie, G., Li, M., Li, B., Guo, S., Wang, Y., Liu, J., Miao, R., Hou, W., & Wei, X. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.179014
Zhou, J., Liu, F., Gao, T., & Yang, Y. (2026) · Journal of Molecular Histology · doi:10.1007/s10735-026-10940-x
Fei, Y., Lu, J., Yu, Z., Xu, C., Tian, M., Li, Q., Ye, H., Lu, Y., Shen, W., He, Q., et al. (2026) · Cancer Management and Research · doi:10.2147/cmar.s613568
Ibrahim, M. L., Foresman, D., Zheng, H., Liu, X., Xie, M., Boyle, T. A., Johnson, J., Rodríguez, P. C., Abate‐Daga, D., Ruffell, B., et al. (2026) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-26-0213
In vivo CRISPR screens identify dual functions of DNMT3A in mediating tumor immune evasion
Zhao, J., Deng, Y., Chen, H., Zhou, X., Yin, S., Qian, Q., Xie, X., Chen, Q., Zhang, J., Fan, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77495-z
Du, P. P., Kohno, S., Wang, M., Papanicolaou, M., Vaughan-Jackson, A., Daigh, L. H., Peng, Q., Spees, K., McCormick, A. K., Diehl, M. I., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.16.752238
Tiu, C., Yau, W., Tenev, T., Lionarons, D., Leung, C., Perez, V. S., Codacci-Pisanelli, G., Lai, X., Zachariou, A., Hussain, A., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77552-7
Metadata
- Authors
- Kearney, C. J., Vervoort, S. J., Hogg, S. J., Ramsbottom, K. M., Freeman, A. J., Lalaoui, N., Pijpers, L., Michie, J., Brown, K. K., Knight, D. A., Sutton, V., Beavis, P. A., Voskoboinik, I., Darcy, P. K., Silke, J., Trapani, J. A., Johnstone, R. W., & Oliaro, J.
- Affiliations
- The University of Melbourne (AU)
- Peter MacCallum Cancer Centre (AU)
- Walter and Eliza Hall Institute of Medical Research (AU)
- Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria 3052, Australia.
- Corresponding author
- Kearney, Conor J.
- Vervoort, Stephin J.
- Johnstone, Ricky W.
- Oliaro, Jane
- ORCID
- Venue
- Science Immunology
- Published
- 2018-05-04
- Volume
- 3
- Issue
- 23
- ISSN
- 2470-9468 (ISSN-L)
- OpenAlex
- W2804568941
- Cited by
- 381
- References
- 46
- Citations by year
- 2026: 20 · 2025: 59 · 2024: 61 · 2023: 59 · 2022: 55 · 2021: 54 · 2020: 38 · 2019: 26 · 2018: 7
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Victorian Cancer Agency
- National Health and Medical Research Council
- Cancer Council Victoria
- National Breast Cancer Foundation (ECF-17-005)
- Netherlands Organization for Scientific Research
- Peter MacCallum Cancer Foundation
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Keywords
- tumor immune evasion, TNF signaling, T cell-mediated killing, NK cell-mediated killing, interferon signaling, antigen presentation, immune surveillance, tumor immunology
- MeSH terms
- Animals, Interferon-gamma, Killer Cells, Natural, Tumor Necrosis Factor-alpha, Antigen Presentation, CD8-Positive T-Lymphocytes, Tumor Escape, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.